Sun Pharma to Settle US Generics Pricing Case for $200 Million
Sun Pharmaceutical Industries Ltd. settled claims worth $200 million in an antitrust case in Pennsylvania alleging that the firm, along with others, colluded to fix prices of generic drugs. The units of India’s number one drugmaker — Sun Pharmaceutical Industries …
Source: Claims Journal